<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig5">
 <label>Fig. 5</label>
 <caption>
  <p>Isobologram showing the 
   <italic>in vitro</italic> interaction between amantadine and doxorubicin, cisplatin or 5FU in HCT8
   <sup>WT</sup> and HCT8
   <sup>RETO</sup> cells. Dose-response curves are based on the respective IC
   <sub>50</sub> values calculated after 24 hours of incubation. Amantadine-doxorubicin are synergistic in HCT8 
   <sup>WT/RETO</sup> (
   <bold>a &amp; b</bold>). Amantadine-cisplatin are additive in HCT8 wildtype (
   <bold>c</bold>) and synergistic in HCT8
   <sup>RETO</sup> (
   <bold>d</bold>). Amantadine-5FU are synergistic in RETO (
   <bold>f</bold>) but antagonistic in HCT8
   <sup>WT</sup> (
   <bold>e</bold>). 
   <italic>n</italic> = 3 independent experiments
  </p>
 </caption>
 <graphic xlink:href="13046_2015_199_Fig5_HTML" id="MO5" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
